1-(2-((2-((3-chloro-2-fluorobenzyl)amino)-2-oxoethyl)(cyclopropyl)amino)-2-oxoethyl)-5-(4-(4-fluorobenzyl)piperazine-1-carboxamido)-1H-indazole-3-carboxamide

ID: ALA5219562

PubChem CID: 130300248

Max Phase: Preclinical

Molecular Formula: C34H35ClF2N8O4

Molecular Weight: 693.16

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)c1nn(CC(=O)N(CC(=O)NCc2cccc(Cl)c2F)C2CC2)c2ccc(NC(=O)N3CCN(Cc4ccc(F)cc4)CC3)cc12

Standard InChI:  InChI=1S/C34H35ClF2N8O4/c35-27-3-1-2-22(31(27)37)17-39-29(46)19-44(25-9-10-25)30(47)20-45-28-11-8-24(16-26(28)32(41-45)33(38)48)40-34(49)43-14-12-42(13-15-43)18-21-4-6-23(36)7-5-21/h1-8,11,16,25H,9-10,12-15,17-20H2,(H2,38,48)(H,39,46)(H,40,49)

Standard InChI Key:  BEQIHGYSIRUYPP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 49 54  0  0  0  0  0  0  0  0999 V2000
   -5.4170    1.2604    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8337    1.8438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0368    1.6302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8233    0.8333    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4066    0.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2035    0.4635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0264    0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8128   -0.1769    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4430    1.2032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6461    0.9897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4259    0.1912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6269   -0.0115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2425   -0.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6498   -1.4490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4746   -1.4551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2320   -2.1605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5717   -0.6005    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6929    0.1913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0520    0.5741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2713    1.3694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0670    1.5770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4044    0.6091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1219    0.2019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1280   -0.6230    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8333    0.6196    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5508    0.2124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2622    0.6301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9797    0.2229    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6912    0.6407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4086    0.2333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4147   -0.5950    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1342   -0.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8413   -0.5808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8352    0.2443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1202    0.6510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1142    1.4760    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.5467    0.6621    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.2561    1.4551    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8333    1.4446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2466    2.1605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4216    2.1596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2140    1.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7973    0.8906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5840    0.0936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1662   -0.4874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.9633   -0.2738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.1773    0.5185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5977    1.1051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.5467   -0.8572    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  1  6  1  0
  7  4  1  0
  7  8  2  0
  9  7  1  0
 10  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 13 17  2  0
 18 17  1  0
 19 18  1  0
 12 19  1  0
 19 20  2  0
 20 21  1  0
 21 10  2  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 30  2  0
 35 36  1  0
 34 37  1  0
 27 38  2  0
 39 25  1  0
 39 40  1  0
 40 41  1  0
 39 41  1  0
  1 42  1  0
 42 43  1  0
 44 43  2  0
 45 44  1  0
 46 45  2  0
 47 46  1  0
 48 47  2  0
 43 48  1  0
 46 49  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5219562

    ---

Associated Targets(Human)

CFD Tchem Complement factor D (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 693.16Molecular Weight (Monoisotopic): 692.2438AlogP: 3.72#Rotatable Bonds: 11
Polar Surface Area: 145.90Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.93CX Basic pKa: 6.21CX LogP: 2.67CX LogD: 2.65
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.22Np Likeness Score: -2.19

References

1. Zhang W, Wu M, Vadlakonda S, Juarez L, Cheng X, Muppa S, Chintareddy V, Vogeti L, Kellogg-Yelder D, Williams J, Polach K, Chen X, Raman K, Babu YS, Kotian P..  (2022)  Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors.,  74  [PMID:36272185] [10.1016/j.bmc.2022.117034]

Source